Isolation and characterization of sixteen novel p53 response genes
Authors:
- Corinne KosticCKCorinne Kostic
- Phillip H ShawPSPhillip H Shaw
- 17 August 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (35) , 3978-3987
Abstract
The EB-1 cell line is a stable transfectant of EB, a p53 null colon carcinoma cell line, with an inducible promoter controlling expression of a wild type p53 cDNA. The induced p53 is transcriptionally active and gives rise to apoptosis in these cells. Using this cellular model for presence or absence of the transcription factor p53 and transactivated genes, the Suppression Subtractive Hybridization (SSH) technique permitted the isolation of 17 mRNA candidates (GIPs-Genes induced by p53), whose expression appears to be p53-dependent. Identity has been established for nine of the 17 isolated candidates. These are HGFL/MSP, Zap-70, APOBEC2, Ponsin/SH3P12/CAP/FLAF2, CDCrel2b/H5/Pnutl2, IgG, lats 2, cytokeratin 15 and PIG-3 (quinone oxidoreductase). The latter gene is the only GIP previously demonstrated to be p53 regulated. Of the eight remaining GIPs, six correspond to Unigene clusters. One candidate, GIP #1, is significantly homologous (72% identity) to a chicken zinc finger protein, CTCF, which binds to insulator elements and thus attenuates enhancer cross-talk between physically adjacent promoters. The p53-dependent expression of GIPs was confirmed by dependence of expression upon induction of wt p53 expression in the EB-1 cellular model and by up-regulation following activation of an endogenous wt p53 by treatment with adriamycin. Oncogene (2000) 19, 3978 - 3987.Keywords
This publication has 70 references indexed in Scilit:
- wt p53 dependent expression of a membrane-associated isoform of adenylate kinaseOncogene, 1999
- APOBEC-2, a Cardiac- and Skeletal Muscle-Specific Member of the Cytidine Deaminase Supergene FamilyBiochemical and Biophysical Research Communications, 1999
- Characterization of a Novel Gene,PNUTL2,on Human Chromosome 17q22–q23 and Its Exclusion as the Meckel Syndrome GeneGenomics, 1999
- The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell lineMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- DNA-Dependent Protein Kinase Inhibitor (OK-1035) Suppresses p21 Expression in HCT116 Cells Containing Wild-Type p53 Induced by AdriamycinBiochemical and Biophysical Research Communications, 1996
- Absence of Radiation-induced G1 Arrest in Two Closely Related Human Lymphoblast Cell Lines That Differ in p53 StatusJournal of Biological Chemistry, 1995
- p53 tagged sites from human genomic DNAHuman Molecular Genetics, 1994
- Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53Experimental Cell Research, 1992
- The p53 tumour suppressor geneNature, 1991
- Basic local alignment search toolJournal of Molecular Biology, 1990